FDA Experts Reject Third Dose Of Vaccine For General US Population

Related news

The advisory committee of the US Food and Drug Administration (FDA) has rejected this Friday the plan to give a booster dose of the Pfizer vaccine against covid-19 in the country, as the Government of President Joe Biden wanted.
The vote ended with 16 members in favor and 3 against. Pfizer had requested approval for people over 16 years of age for this booster 6 months after the second dose.
After a prolonged discussion of several hours, the panel considered insufficient the data provided by the pharmacist about the relevance of this third dose for the majority of the population.
“This is a great decision, I don’t understand why we have to rush. I don’t understand why we can’t spend more time looking at the data, “said Dr. Paul Offit, from the Center for Vaccine Education at Children’s Hospital of Philadelphia, during the discussion.
FDA experts did show themselves more open to give the green light to the reinforcement plan for vulnerable groups, like people over 60 or 65, but did not make a firm decision about it, so the discussion continues.
The FDA’s decision is a blow to the US President’s government, which had begun making plans to start the administration of this third dose by the end of the month. The FDA advisory panel vote is not binding, but is generally respected by the agency.


Leave a Comment